Cargando…

PLK1 Inhibition Induces Immunogenic Cell Death and Enhances Immunity against NSCLC

PLK1 inhibitors were shown, in vitro and in vivo, to possess inhibitory activities against non-small cell lung cancer (NSCLC), and such inhibition has been proven by clinical trials. However, it remains unclear whether and how the immune microenvironment is associated with the action. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Yang, Qifan, Lu, Lisen, Tuo, Zhan, Shou, Zhexing, Cheng, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436107/ https://www.ncbi.nlm.nih.gov/pubmed/34522178 http://dx.doi.org/10.7150/ijms.60135

Ejemplares similares

High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC
por: Montaudon, Elodie, et al.
Publicado: (2021)

Dual Inhibition of γ-Tubulin and Plk1 Induces Mitotic Cell Death
por: Ebisu, Haruna, et al.
Publicado: (2021)

Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest
por: Han, Bingjie, et al.
Publicado: (2022)

Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
por: Nam, Gi-Hoon, et al.
Publicado: (2018)

Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2020)

PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC
por: Kim, Da-Eun, et al.
Publicado: (2023)

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
por: Koncar, Robert F., et al.
Publicado: (2017)

Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations
por: Normandin, Karine, et al.
Publicado: (2023)

Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2021)

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
por: Kumar, Shiv, et al.
Publicado: (2015)

Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity
por: Moriya, Taiki, et al.
Publicado: (2021)

Immunogenicity of cell death driven by immune effectors
por: Galluzzi, Lorenzo, et al.
Publicado: (2020)

Immunogenic cell death in a combined synergic gene- and immune-therapy against cancer
por: Nayagom, Benjamin, et al.
Publicado: (2019)

Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance
por: Mezzapelle, Rosanna, et al.
Publicado: (2021)

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
por: Wang, Ting, et al.
Publicado: (2023)

Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
por: Wang-Bishop, Lihong, et al.
Publicado: (2020)

Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
por: Wang, Jieqiong, et al.
Publicado: (2016)

Liaisons between Survivin and Plk1 during Cell Division and Cell Death
por: Colnaghi, Rita, et al.
Publicado: (2010)

PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation
por: Yu, Jizhang, et al.
Publicado: (2020)

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy
por: Jafari, Sevda, et al.
Publicado: (2023)

Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle
por: Yang, Jie, et al.
Publicado: (2021)

Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
por: Li, Mengyuan, et al.
Publicado: (2018)

Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021)

PLK1 inhibition-based combination therapies for cancer management
por: Su, Shengqin, et al.
Publicado: (2021)

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
por: Chiappa, Michela, et al.
Publicado: (2022)

From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment
por: Fabian, Kellsye P., et al.
Publicado: (2021)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019)

Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer
por: Quan, Xingguo, et al.
Publicado: (2020)

PLK:Δgra9 Live Attenuated Strain Induces Protective Immunity Against Acute and Chronic Toxoplasmosis
por: Li, Jixu, et al.
Publicado: (2021)

PLK1 protects against sepsis-induced intestinal barrier dysfunction
por: Cao, Yingya, et al.
Publicado: (2018)

TRIM37 controls cancer-specific vulnerability to PLK4 inhibition
por: Meitinger, Franz, et al.
Publicado: (2020)

Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death
por: Huo, Xiaolei, et al.
Publicado: (2022)

Asterless amplifies Plk4
por: Short, Ben
Publicado: (2015)

Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma
por: He, Chen, et al.
Publicado: (2023)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma
por: Smith, Henry G, et al.
Publicado: (2020)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells
por: Harris, Peter S, et al.
Publicado: (2012)

Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity
por: Sethuraman, Sri Nandhini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lg5hfvev8md1f2leaotqndqej0